Exploring the Mechanism of Qigesan in Treating Esophageal Carcinoma Based on Network Pharmacology, Molecular Docking, and MolecularDynamics Simulation
These findings provide a comprehensive elucidation of the multi-component, multi-target therapeutic strategy employed by QGS in the treatment of EC, laying a solid theoretical foundation for subsequent pharmacological development and clinical validation.
Authors
- Shixin Ye (ORCID: https://orcid.org/0000-0002-9254-9409)
- Jiayi Yin (ORCID: https://orcid.org/0000-0001-9115-4571)
- W. S. Li
- Xiongfeng Huang
- yousheng hu
- Shulei Zhang (ORCID: https://orcid.org/0000-0002-9794-4088)
- Bugao Zhou
- Meihua Tang
- Haolan You
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- Nanchang University (CN)
- Nanchang Center for Disease Control and Prevention (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Current Computer - Aided Drug Design
- Published
- 2026-01-12
- DOI
- https://doi.org/10.2174/0115734099414317251126094602
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00